- Home
- ADMA vs INSP Comparison
ADMA vs INSP Comparison
Compare ADMA & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- INSP
- Stock Information
- Founded
- ADMA 2004
- INSP 2007
- Country
- ADMA United States
- INSP United States
- Employees
- ADMA N/A
- INSP N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- INSP Medical/Dental Instruments
- Sector
- ADMA Health Care
- INSP Health Care
- Exchange
- ADMA Nasdaq
- INSP Nasdaq
- Market Cap
- ADMA 3.5B
- INSP 3.8B
- IPO Year
- ADMA N/A
- INSP 2018
- Fundamental
- Price
- ADMA $16.18
- INSP $90.65
- Analyst Decision
- ADMA Strong Buy
- INSP Buy
- Analyst Count
- ADMA 3
- INSP 16
- Target Price
- ADMA $27.67
- INSP $139.40
- AVG Volume (30 Days)
- ADMA 3.7M
- INSP 1.2M
- Earning Date
- ADMA 11-05-2025
- INSP 11-03-2025
- Dividend Yield
- ADMA N/A
- INSP N/A
- EPS Growth
- ADMA 205.35
- INSP 34.77
- EPS
- ADMA 0.86
- INSP 1.48
- Revenue
- ADMA $488,559,000.00
- INSP $882,622,000.00
- Revenue This Year
- ADMA $21.08
- INSP $14.83
- Revenue Next Year
- ADMA $25.98
- INSP $14.44
- P/E Ratio
- ADMA $18.73
- INSP $61.37
- Revenue Growth
- ADMA 27.63
- INSP 16.81
- 52 Week Low
- ADMA $13.50
- INSP $70.77
- 52 Week High
- ADMA $25.67
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- ADMA 58.87
- INSP 63.69
- Support Level
- ADMA $13.76
- INSP $79.61
- Resistance Level
- ADMA $15.65
- INSP $89.44
- Average True Range (ATR)
- ADMA 0.78
- INSP 3.83
- MACD
- ADMA 0.12
- INSP 1.61
- Stochastic Oscillator
- ADMA 94.90
- INSP 94.08
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.